Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas - Join Clinical Trial NCTNCT05751798
How to Join This Clinical Trial - NCTNCT05751798
Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for Solid Advanced Tumor, Lymphoma, NSCLC (Non-small Cell Lung Cancer). This study is currently enrolling participants.
Am I Eligible for This Clinical Trial?
This clinical research study is looking for participants with Solid Advanced Tumor, Lymphoma, NSCLC (Non-small Cell Lung Cancer). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.
- Condition Being Studied
- Solid Advanced Tumor, Lymphoma, NSCLC (Non-small Cell Lung Cancer)
- Treatment Being Tested
- Investigational treatment
- Study Phase
- PHASE1, PHASE2 - Safety and effectiveness study
- Enrollment Status
- Currently enrolling participants
- Study Identifier
- NCTNCT05751798 - ClinicalTrials.gov Identifier
- Sponsored By
- Study sponsor
What to Expect as a Participant
Participating in this clinical trial involves:
- Initial screening to determine eligibility
- Regular study visits and health assessments
- Receiving the study treatment or placebo
- Medical monitoring and follow-up care
- Contributing to medical research that may help others
- Potential access to new treatments before they're widely available
Clinical Trial Benefits and Compensation
Participants in this clinical research study may receive:
- Close medical monitoring by healthcare professionals
- Access to potential new treatments
- Compensation for time and travel (varies by study)
- No-cost study-related medical care
- The opportunity to help advance medical knowledge
Where Is This Clinical Trial Located?
This study is enrolling participants at 10 locations. Find a study site near you:
Clinical Research Site
Anderlecht, 1070 - Belgium
Status: RECRUITING
Clinical Research Site
Edegem, 11013 - Belgium
Status: NOT_YET_RECRUITING
Clinical Research Site
Lyon, 69373 - France
Status: RECRUITING
Clinical Research Site
Paris, 75014 - France
Status: RECRUITING
Clinical Research Site
Rennes, 35000 - France
Status: COMPLETED
Clinical Research Site
Saint-Herblain, 44805 - France
Status: RECRUITING
Clinical Research Site
Toulouse, 31059 - France
Status: RECRUITING
Clinical Research Site
Villejuif, 94805 - France
Status: RECRUITING
Clinical Research Site
A Coruña, - Spain
Status: ACTIVE_NOT_RECRUITING
Clinical Research Site
Málaga, 2901 - Spain
Status: NOT_YET_RECRUITING
How to Enroll in This Study
To learn more about participating in this PHASE1, PHASE2 clinical trial for Solid Advanced Tumor, Lymphoma, NSCLC (Non-small Cell Lung Cancer):
- Review the eligibility criteria with your healthcare provider
- Contact the study team for a pre-screening interview
- Schedule an in-person screening visit if eligible
- Review and sign the informed consent form
- Begin participation in the clinical trial
Why Choose Quri.ai Study Finder
Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:
- Discover clinical trials before competitors
- Access exclusive contact information
- Track sponsor pipelines and opportunities
- Connect with decision makers directly
- Win more business partnerships